Litigation Details for Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical, Inc. (D. Del. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-04-13 |
Court | District Court, D. Delaware | Date Terminated | 2019-03-06 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,239,124; 6,455,518; 7,297,703; 7,741,338; 8,410,131; 8,778,962 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical, Inc.
Details for Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-07-03 | 30 | Notice of Service | Klibanov Concerning the Validity of U.S. Patent Nos. 7,297,703 and 7,741,338, (2) Responsive Expert Report…Ess, M.D., Ph.D. Regarding the Validity of U.S. Patent No. 8,778,962, (3) Rebuttal Expert Report of Dr…Dr. Krishna V. Komanduri on the Validity of U.S. Patent Nos. 8,410,131 and 8,778,962, and (4) Rebuttal … Vogelzang, M.D. Regarding the Validity of U.S. Patent No. 8,410,131 filed by Novartis AG, Novartis Pharmaceuticals…2017 7 March 2019 1:17-cv-00420 830 Patent None District Court, D. Delaware | External link to document |
2018-08-27 | 31 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 8,410,131; 8,778,962. (…2017 7 March 2019 1:17-cv-00420 830 Patent None District Court, D. Delaware | External link to document |
2017-05-16 | 8 | FINAL JUDGMENT regarding U.S. Patent Nos. 5,665,772, 6,239,124, and 6,455,518. Signed by Judge Richard…2017 7 March 2019 1:17-cv-00420 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |